Browse > Article
http://dx.doi.org/10.7732/kjpr.2020.33.6.659

Adenophorae Radix Attenuates Mast Cell-mediated Allergic Inflammation through Down-regulation of NF-κB/ Caspase-1 Activation  

Myung, Noh-Yil (Department of Oriental Medicine and Healthcare, Wonkwang Digital University)
Publication Information
Korean Journal of Plant Resources / v.33, no.6, 2020 , pp. 659-665 More about this Journal
Abstract
Adenophorae Radix (AR) has been used as a traditional medicine for various diseases. However, the regulatory mechanisms of AR in allergic inflammation are not yet understood. The present study was conducted to investigate the effect and mechanisms of AR on the mast cell-mediated allergic response. To determine the pharmacological mechanisms of AR in allergic inflammation, we evaluated the effects of AR on the production of tumor necrosis factor (TNF)-α, interleukin (IL)-6, IL-1β and IL-8 as well as the activation of nuclear factor-κB (NF-κB) and caspase-1 in phorbol 12-myristate 13-acetate plus calcium ionophore A23187 (PMACI)-stimulated human mast cells (HMC-1). Our results demonstrated that AR effectively attenuated the PMACI-induced production of TNF-α, IL-6, IL-1β and IL-8 in stimulated HMC-1. Additionally, we showed that the inhibitory effect of AR on inflammatory cytokines in PMACI-stimulated HMC-1 cells involved the suppression of the activation NF-kB/caspase-1 in PMACI-stimulated HMC-1. Collectively, these findings provide experimental evidence that AR may be a useful candidate for the treatment of allergic inflammation.
Keywords
Adenophorae Radix; Allergic inflammation; Caspase-1; Inflammatory cytokines; Mast cells; Nuclear factor-${\kappa}B$;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Gilmore, T.D. and M.R. Garbati. 2011. Inhibition of NF-κB signaling as a strategy in disease therapy. Curr. Top. Microbiol. Immunol. 349: 245-263.
2 Han, N.R., P.D. Moon, N.R. Kim, H.Y. Kim, H.J. Jeong and H.M. Kim. 2017. Schisandra chinensis and its main constituent schizandrin attenuate allergic reactions by down-regulating caspase-1 in ovalbumin-sensitized mice. Am. J. Chin. Med. 45:159-172.   DOI
3 Hawiger, J. 2001. Innate immunity and inflammation: A transcriptional paradigm. Immunol. Res. 23:99-109.   DOI
4 Kim, H.J. and S.H. Kang. 2017. Ethnobotany, phytochemistry, pharmacology of the Korean Campanulaceae: A comprehensive review. Korean J. Plant Res. 30:240-264.   DOI
5 Kim, H.Y., S.Y. Nam, S.Y. Hwang, H.M. Kim and H.J. Jeong. 2016. Atractylone, an active constituent of KMP6, attenuates allergic inflammation on allergic rhinitis in vitro and in vivo models. Mol. Immunol. 78:121-132.   DOI
6 Kim, J.Y., K.W. Park, K.D. Moon, M.K. Lee, J. Choi, S.T. Yee, K.H. Shim and K.I. Seo. 2008. Induction of apoptosis in HT-29 colon cancer cells by crude saponin from Platycodi Radix. Food Chem. Toxicol. 46:3753-3758.   DOI
7 Kim, S. J. , M. C. Kim, J. Y. Um and S. H. Hong. 2010. The beneficial effect of vanillic acid on ulcerative colitis. Molecules 15:7208-7217.   DOI
8 Kuida, K., J.A. Lippke and G. Ku. 1995. Altered cytokine export and apoptosis in mice deficient in interleukin-1B converting enzyme. Science 267:2000-2002.   DOI
9 Furue, M. and T. Kadono. 2017. "Inflammatory skin march" in atopic dermatitis and psoriasis. Inflamm. Res. 66:833-842.   DOI
10 Lamkanfi, M., M. Kalai, X. Saelens, W. Declercq and P. Vandenabeele. 2004. Caspase-1 activates nuclear factor of the kappa-enhancer in B cells independently of its enzymatic activity. J. Biol. Chem. 279:24785-24793.   DOI
11 Lee, Y.S., S.B. Han, H.J. Ham, J.H. Park, J.S. Lee, D.Y. Hwang, Y.S. Jung, D.Y. Yoon and J.T. Hong. 2020. IL-32γ suppressed atopic dermatitis through inhibition of miR-205 expression via inactivation of nuclear factor-kappa B. J. Allergy Clin. Immunol. 146:156-168.   DOI
12 Li, J.W., Y. Liu, B.H. Li, Y.Y. Wang, H. Wang and C.L. Zhou. 2016. A polysaccharide purified from Radix Adenophorae promotes cell activation and pro-inflammatory cytokine production in murine RAW264.7 macrophages. Chin. J. Nat. Med. 14:370-376.   DOI
13 Modena, B.D., K. Dazy and A.A. White. 2016. Emerging concepts: mast cell involvement in allergic diseases. Transl. Res.174: 98-121.   DOI
14 Lim, J.M., B. Lee, J.H. Min, E.Y. Kim, J.H. Kim, S. Hong, J.J. Kim, Y. Sohn and H.S. Jung. 2018. Effect of peiminine on DNCB-induced atopic dermatitis by inhibiting inflammatory cytokine expression in vivo and in vitro. Int. Immunopharmacol. 56:135-142.   DOI
15 Martin, R.A., J.L. Ather, L.K. Lundblad, B.T. Suratt, J.E. Boyson, R.C. Budd, J.F. Alcorn, R.A. Flavell, S.C. Eisenbarth and M.E. Poynter. 2013. Interleukin-1 receptor and caspase-1 are required for the Th17 response in nitrogen dioxide-promoted allergic airway disease. Am. J. Respir. Cell Mol. Biol. 48:655-664.   DOI
16 Mitchell, J.P. and R.J. Carmody. 2018. NF-κB and the transcriptional control of inflammation. Int. Rev. Cell Mol. Biol. 335:41-84.   DOI
17 Sakamoto, T., W. Ohashi, K. Tomita , K. Hattori , N. Matsuda and Y. Hattori. 2018. Anti-inflammatory properties of cilostazol: Its interruption of DNA binding activity of NF-kappaB from the Toll-like receptor signaling pathways. Int Immunopharmacol. 62:120-131.   DOI
18 Siegmund, B. , H. A. Lehr, G. Fantuzzi and C. A. Dinarello. 2001. IL-1 betaconverting enzyme (caspase-1) in intestinal inflammation. PNASU. 98:13249-13254.   DOI
19 Song, P., J. Xia, C. Rezeng, L. Tong and W. Tang. 2016. Traditional, complementary, and alternative medicine: Focusing on research into traditional Tibetan medicine in China. Biosci. Trends 10:163-170.   DOI
20 Theoharides, T.C., I. Tsilioni and H. Ren. 2019. Recent advances in our understanding of mast cell activation - or should it be mast cell mediator disorders? Expert Rev. Clin. Immunol. 15:639-656.   DOI
21 Edwards, M.R., K. Strong, A. Cameron, R.P. Walton, D.J. Jackson and S.L. Johnston. 2017. Viral infections in allergy and immunology: How allergic inflammation influences viral infections and illness. J. Allergy Clin. Immunol. 140:909-920.   DOI
22 Birrell, M.A., E. Hardaker, S. Wong, K. McCluskie, M. Catley, J. De Alba, R. Newton, S. Haj-Yahia, K.T. Pun, C.J. Watts, R.J. Shaw, T.J. Savage and M.G. Belvisi. 2005. Ikappa-B kinase-2 inhibitor blocks inflammation in human airway smooth muscle and a rat model of asthma. Am. J. Respir. Crit. Care Med. 172:962-971.   DOI
23 Bouchier-Hayes, L. and S.J. Martin. 2004. CARDINAL roles in apoptosis and NFkappaB activation. Vitam. Horm. 67:133-147.   DOI
24 Caughey, G.H. 2016. Mast cell proteases as pharmacological targets. Eur. J. Pharmacol. 778:44-55.   DOI
25 DiDonato, J.A., F. Mercurio and M. Karin. 2012. NF-κB and the link between inflammation and cancer. Immunol. Rev. 246:379-400.   DOI